{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:24:41Z","timestamp":1761708281369},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ygyno.2008.09.039","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T12:22:01Z","timestamp":1226578921000},"page":"229-234","source":"Crossref","is-referenced-by-count":25,"title":["Cyr61, a member of ccn (connective tissue growth factor\/cysteine-rich 61\/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype"],"prefix":"10.1016","volume":"112","author":[{"given":"Hidemichi","family":"Watari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed K.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Sakuragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.09.039_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-5793(93)80155-N","article-title":"The modular architecture of a new family of growth regulators related to connective tissue growth factor","volume":"327","author":"Bork","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ygyno.2008.09.039_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2867-3-15","article-title":"A structural approach to the role of CCN (CYR61\/CTGF\/NOV) proteins in tumourigenesis","volume":"3","author":"Planque","year":"2003","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ygyno.2008.09.039_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.0.1780169","article-title":"The CCN family: a new stimulus package","volume":"178","author":"Brigstock","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ygyno.2008.09.039_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1023823803510","article-title":"Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine\u2013rich 61 (CYR61)","volume":"5","author":"Brigstock","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ygyno.2008.09.039_bib5","first-page":"8917","article-title":"Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features","volume":"61","author":"Xie","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.039_bib6","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1074\/jbc.M009755200","article-title":"Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease","volume":"276","author":"Xie","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.039_bib7","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1073\/pnas.95.11.6355","article-title":"Cyr61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumour growth","volume":"95","author":"Babic","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2008.09.039_bib8","doi-asserted-by":"crossref","first-page":"47709","DOI":"10.1074\/jbc.M107878200","article-title":"Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer","volume":"276","author":"Tong","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.039_bib9","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/sj.onc.1207628","article-title":"Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway","volume":"23","author":"Tong","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2008.09.039_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1097-0045(19980701)36:2<85::AID-PROS3>3.0.CO;2-D","article-title":"Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer","volume":"36","author":"Pilarsky","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.ygyno.2008.09.039_bib11","first-page":"68","article-title":"Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study","volume":"9","author":"Wasenius","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.039_bib12","doi-asserted-by":"crossref","first-page":"53087","DOI":"10.1074\/jbc.M410254200","article-title":"Cyr61 suppresses growth of human endometrial cancer cells","volume":"279","author":"Chien","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.039_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.AOG.0000269047.46078.28","article-title":"Endometrial expression of Cyr61. A marker of estrogenic activity in normal and abnormal endometrium","volume":"110","author":"MacLaughlan","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.039_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2004.11.026","article-title":"Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer","volume":"96","author":"Watari","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2008.09.039_bib15","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1158\/1078-0432.CCR-0659-03","article-title":"Levels of expression of Cyr61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas","volume":"10","author":"Xie","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.039_bib16","doi-asserted-by":"crossref","first-page":"386.e1","DOI":"10.1016\/j.ajog.2007.01.004","article-title":"GPR30: a novel indicator of poor survival for endometrial carcinoma","volume":"196","author":"Singh","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2008.09.039_bib17","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-05-0231","article-title":"Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells","volume":"11","author":"Gery","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2008.09.039_bib18","doi-asserted-by":"crossref","first-page":"24015","DOI":"10.1074\/jbc.M402305200","article-title":"Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7cells by a mechanism of NF-kB-dependent XIAP up-regulation","volume":"279","author":"Lin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2008.09.039_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF01806148","article-title":"Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma","volume":"38","author":"Bonetti","year":"1996","journal-title":"Breast Cancer Rfes. Treat."},{"key":"10.1016\/j.ygyno.2008.09.039_bib20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0959-8049(05)80124-8","article-title":"DNA flowcytometry and response to preoperative chemotherapy for primary breast cancer","volume":"28","author":"O\u2019Reilly","year":"1992","journal-title":"Eur. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808007956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808007956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T11:40:38Z","timestamp":1557920438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808007956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0090825808007956"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.09.039","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}